Javelin Pharmaceuticals

Mergers and acquisitions propel some of the more dramatic shifts in pharma, an industry characterized by constant change. This article examines the financial performance between 2006 and 2015 of five

Novo Gets Saxenda Approval For Christmas FDA gave Novo Nordisk AS an early Christmas gift with the Dec. 23 approval of Saxenda (liraglutide) for chronic weight management, with no requirement fo

Asmacure, a clinical-stage biopharma company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, has appointed Martin Driscoll chief

Hospira's CEO Christopher Begley and chief operational officer Terrence Kearney are to resign from their positions, having both served at the company since its foundation in 2004. Mr Begley will conti